Filing Details
- Accession Number:
- 0001375852-19-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-26 17:37:00
- Reporting Period:
- 2019-06-25
- Accepted Time:
- 2019-06-26 17:37:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375852 | E Scott Lamb | 951 Calle Amanecer San Clemente CA 92673 | Chief Financial Officer, | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-25 | 21,675 | $58.79 | 34,984 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2019-06-25 | 21,675 | $250.00 | 13,309 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-06-26 | 3,325 | $58.79 | 16,634 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2019-06-26 | 3,325 | $250.00 | 13,309 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-06-25 | 21,675 | $58.79 | 21,675 | $58.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-06-26 | 3,325 | $58.79 | 3,325 | $58.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,325 | 2024-02-24 | No | 4 | X | Direct | |
| 75,000 | 2024-02-24 | No | 4 | X | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019.
- All shares sold were sold at the exact price disclosed.
- Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
- Transaction is the exercise of a derivative security; see Column 2.
Billionaire Hedge Funds
